All Posts By

Κωνσταντίνος Τσιούφης

PubMed Recent Publications with Links

By Χωρίς κατηγορία

Σύνολο Δημοσιεύσεων: 418 Πρόσφατες Δημοσιεύσεις στο PubMed: -> IVABRADINE AND METOPROLOL IN FIXED DOSE COMBINATION: WHEN, WHY AND HOW TO USE IT. -> Hypertension and atrial fibrillation: epidemiological data, pathogenesis and therapeutic implications. -> Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: a…

Read More

Vote for the Representative of the Presidents of European Hypertension National Societies to ESH Council

By Χωρίς κατηγορία
#qp_main2360412 .qp_btna:hover input {background-color: rgb(0, 53, 95)!important} #qp_all2360412 {max-width:815px; margin:0 auto;}Representative of the Presidents of European Hypertension National Societies to ESH CouncilCode:Maria DorobantuDénes PállSurvey Maker | Make Surveys in Minutes | PollMaker
Read More

Ivabradine and metoprolol in fixed dose combination: When, why and how to use it.

By Δημοσιεύσεις

Δημοσίευση στις 2019/5/21 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31108185   Katsi V, Skalis G, Kallistratos MS, Tsioufis K, Makris T, Manolis AJ, Tousoulis D. Abstract Heart rate is an important factor in coronary artery disease and its manifestations, and as such has been considered as a possible target for therapy. Although in epidemiological,…

Read More

Peritoneal dialysis as a therapeutic solution in elderly patients with cardiorenal syndrome and heart failure: A case-series report.

By Δημοσιεύσεις

Δημοσίευση στις 2019/5/6 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31055051   Chrysohoou C, Bougatsos G, Magkas N, Skoumas J, Kapota A, Kopelias J, Bliouras N, Tsioufis K, Petras D, Tousoulis D. Abstract BACKGROUND: The aim of this work was to evaluate the impact of peritoneal dialysis (PD) on venous congestion, right ventricular function, pulmonary…

Read More

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

By Δημοσιεύσεις

Δημοσίευση στις 2019/5/6 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31054483   De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres,…

Read More

Primary aldosteronism: novel insights.

By Δημοσιεύσεις

Δημοσίευση στις 2019/4/17 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30987572   Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, Doumas M. Abstract BACKGROUND: Primary aldosteronism is one of the most common causes of secondary hypertension. Patients with this endocrine syndrome are at increased cardiovascular risk, higher than hypertensive individuals with…

Read More

Incidence, characteristics and outcomes in patients with embolic stroke of undetermined source: A population-based study.

By Δημοσιεύσεις

Δημοσίευση στις 2019/4/16 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30986703   Tsivgoulis G, Kargiotis O, Katsanos AH, Patousi A, Mavridis D, Tsokani S, Pikilidou M, Birbilis T, Mantatzis M, Zompola C, Triantafyllou S, Papanas N0, Skendros P, Terzoudi A, Georgiadis GS, Maltezos E0, Piperidou C, Tsioufis K, Heliopoulos I, Vadikolias K. Abstract Embolic stroke…

Read More

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.

By Δημοσιεύσεις

Δημοσίευση στις 2019/4/14 στο PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30980838   Katsiki N, Dimitriadis G, Hahalis G, Papanas N, Tentolouris N, Triposkiadis F, Tsimihodimos V, Tsioufis C, Mikhailidis DP, Mantzoros C0. Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are oral antidiabetic agents that exert their glucose-lowering effect by increasing renal excretion of glucose. These drugs have…

Read More
error: